Node Negative, ER-
The association between large tumor size and metastatic risk in a majority of clinical cancers has led to questions as to whether these observations are causally related or whether one is simply a marker for the other. The aim of this study was to investigate this question through the analysis of a previously defined “lung metastasis gene-expression signature” (LMS) that mediates experimental breast cancer metastasis selectively to the lung and is expressed by primary human breast cancer with a high risk for developing lung metastasis.
The hypothesis of this study was that the LMS could provide a mechanistic link between metastasis gene expression, accelerated tumor growth, and likelihood of metastatic recurrence.
This dataset contains 58 estrogen receptor-negative samples from a cohort of early stage node negative breast cancer patients. Tumour samples were selected from the tumour bank at the Erasmus Medical Center (Rotterdam, Netherlands).
The complete EMC-344 cohort (as referred to by Minn et al) consists of an additional 286 samples as previously described by Wang et al (GEO accession number GSE2034).
--
--
Microarray analysis was performed with Affymetrix U133A.
Minn, Andy J., Gaorav P. Gupta, David Padua, Paula Bos, Don X. Nguyen, Dimitry Nuyten, Bas Kreike, et al. “Lung Metastasis Genes Couple Breast Tumor Size and Metastatic Spread.” Proceedings of the National Academy of Sciences of the United States of America 104, no. 16 (April 17, 2007): 6740–45. doi:10.1073/pnas.0701138104.
Wang, Yixin, Jan G. M. Klijn, Yi Zhang, Anieta M. Sieuwerts, Maxime P. Look, Fei Yang, Dmitri Talantov, et al. “Gene-Expression Profiles to Predict Distant Metastasis of Lymph-Node-Negative Primary Breast Cancer.” Lancet (London, England) 365, no. 9460 (February 19, 2005): 671–79. doi:10.1016/S0140-6736(05)17947-1.
Sample ID | series | IMS | IBS | IDS | ICR |
---|---|---|---|---|---|
GSM120649 | Erasmus | ClaudinLow | IBD | FID | ICR2 |
GSM120651 | Erasmus | Basal | IBE | FID | ICR4 |
GSM120652 | Erasmus | Her2 | IBD | PID | ICR1 |
GSM120653 | Erasmus | Normal | IBE | NA | ICR1 |
GSM120654 | Erasmus | LumA | IBD | PID | ICR1 |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Series | IMS | IBS | IDS | ICR | Array Sample ID | Sample Title | DMFS 10Y EVENT | DMFS 10Y TIME | Disease Free Survival Event | Distant Met Free Survival Event | Distant Met Free Survival | Age At Initial Pathologic Diagnosis | Lymph Node Status | ER Status | PR Status | Histology Differentiation Grade | Tumor Size Cm | Pathology T Stage | Disease Free Survival Years | Sample Title2 | Lung Metastasis Gene Expression Signature Status | Lung Metastasis Event | Lung Met First Event | Lung Met Free Survival Years |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSM120649 | Erasmus |
ClaudinLow |
IBD |
FID |
ICR2 |
400002598 |
ER negative human primary breast tumor EA02014_41243_H133A_JA-076 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
11.3388 |
76 |
1 |
LungMetastasisFree |
no |
11.3388 |
GSM120651 | Erasmus |
Basal |
IBE |
FID |
ICR4 |
400002599 |
ER negative human primary breast tumor EA02014_41245_H133A_JA-123 |
DistantMetastasisFree |
7.36 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.360655833 |
123 |
1 |
LungMetastasisFree |
no |
7.360655833 |
GSM120652 | Erasmus |
Her2 |
IBD |
PID |
ICR1 |
400002600 |
ER negative human primary breast tumor EA02014_41246_H133A_JA-401 |
DistantMetastasis |
1.02 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
1.019125833 |
401 |
0 |
LungMetastasisFree |
no |
1.019125833 |
GSM120653 | Erasmus |
Normal |
IBE |
NA |
ICR1 |
400002601 |
ER negative human primary breast tumor EA02014_41247_H133A_JA-120 |
DistantMetastasisFree |
8 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.9972675 |
120 |
1 |
LungMetastasisFree |
no |
7.9972675 |
GSM120654 | Erasmus |
LumA |
IBD |
PID |
ICR1 |
400002602 |
ER negative human primary breast tumor EA02014_41248_H133A_JA-131 |
DistantMetastasisFree |
8.11 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.10929 |
131 |
0 |
LungMetastasisFree |
no |
8.10929 |
GSM120655 | Erasmus |
Basal |
IBE |
PID |
ICR2 |
400002603 |
ER negative human primary breast tumor EA02014_41249_H133A_JA-243 |
DistantMetastasis |
0.84 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
0.84153 |
243 |
1 |
LungMetastasis |
yes |
0.84153 |
GSM120656 | Erasmus |
ClaudinLow |
IBD |
WID |
ICR3 |
400002604 |
ER negative human primary breast tumor EA02014_41250_H133A_JA-245 |
DistantMetastasis |
1.87 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
1.874316667 |
245 |
1 |
LungMetastasis |
yes |
1.874316667 |
GSM120657 | Erasmus |
Basal |
IBE |
WID |
ICR3 |
400002605 |
ER negative human primary breast tumor EA02014_41251_H133A_JA-632 |
DistantMetastasisFree |
5.09 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.090164167 |
632 |
1 |
LungMetastasisFree |
no |
5.090164167 |
GSM120658 | Erasmus |
Basal |
IBE |
FID |
ICR4 |
400002606 |
ER negative human primary breast tumor EA02014_41252_H133A_JA-746 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
10.22130833 |
746 |
1 |
LungMetastasisFree |
no |
10.22130833 |
GSM120659 | Erasmus |
Her2 |
IBE |
WID |
ICR4 |
400002607 |
ER negative human primary breast tumor EA02014_41253_H133A_JA-755 |
DistantMetastasisFree |
8.76 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.756833333 |
755 |
0 |
LungMetastasisFree |
no |
8.756833333 |
GSM120660 | Erasmus |
ClaudinLow |
IBD |
WID |
ICR3 |
400002608 |
ER negative human primary breast tumor EA02014_41254_H133A_JA-812 |
DistantMetastasisFree |
9.7 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
9.704916667 |
812 |
1 |
LungMetastasisFree |
no |
9.704916667 |
GSM120661 | Erasmus |
ClaudinLow |
IBD |
WID |
ICR4 |
400002609 |
ER negative human primary breast tumor EA02014_41255_H133A_JA-838 |
DistantMetastasisFree |
7.21 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.213115 |
838 |
0 |
LungMetastasisFree |
no |
7.213115 |
GSM120662 | Erasmus |
LumA |
IBD |
WID |
ICR3 |
400002610 |
ER negative human primary breast tumor EA02014_41256_H133A_JA-872 |
DistantMetastasis |
5.73 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.729508333 |
872 |
0 |
LungMetastasisFree |
no |
5.729508333 |
GSM120663 | Erasmus |
ClaudinLow |
IBD |
FID |
ICR4 |
400002611 |
ER negative human primary breast tumor EA02014_41257_H133A_JA-248 |
DistantMetastasis |
2.41 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
2.412568333 |
248 |
1 |
LungMetastasis |
no |
3.662568333 |
GSM120664 | Erasmus |
Her2 |
IBD |
WID |
ICR3 |
400002612 |
ER negative human primary breast tumor EA02014_41258_H133A_JA-282 |
DistantMetastasisFree |
6.93 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.931694167 |
282 |
0 |
LungMetastasisFree |
no |
6.931694167 |
GSM120665 | Erasmus |
LumB |
IBD |
PID |
ICR1 |
400002613 |
ER negative human primary breast tumor EA02014_41259_H133A_JA-929 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
13.04098333 |
929 |
0 |
LungMetastasisFree |
no |
13.04098333 |
GSM120666 | Erasmus |
Her2 |
IBD |
FID |
ICR4 |
400002614 |
ER negative human primary breast tumor EA02014_41260_H133A_JA-941 |
DistantMetastasisFree |
7.29 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.2896175 |
941 |
0 |
LungMetastasisFree |
no |
7.2896175 |
GSM120667 | Erasmus |
LumB |
IBD |
FID |
ICR4 |
400002615 |
ER negative human primary breast tumor EA02014_41261_H133A_JA-1060 |
DistantMetastasisFree |
5.94 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.939890833 |
1060 |
0 |
LungMetastasisFree |
no |
5.939890833 |
GSM120668 | Erasmus |
Basal |
IBE |
WID |
ICR3 |
400002616 |
ER negative human primary breast tumor EA02014_41262_H133A_JA-1222 |
DistantMetastasis |
0.6 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
0.598360667 |
1222 |
0 |
LungMetastasis |
yes |
0.598360667 |
GSM120669 | Erasmus |
Her2 |
IBD |
WID |
ICR2 |
400002617 |
ER negative human primary breast tumor EA02014_41263_H133A_JA-1582 |
DistantMetastasisFree |
8.02 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.019125833 |
1582 |
0 |
LungMetastasisFree |
no |
8.019125833 |
GSM120670 | Erasmus |
Her2 |
IBD |
WID |
ICR2 |
400002618 |
ER negative human primary breast tumor EA02014_41264_H133A_JA-1487 |
DistantMetastasisFree |
5.88 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.879781667 |
1487 |
0 |
LungMetastasisFree |
no |
5.879781667 |
GSM120671 | Erasmus |
Basal |
IBE |
PID |
ICR2 |
400002619 |
ER negative human primary breast tumor EA02014_41265_H133A_JA-1069 |
DistantMetastasis |
1.97 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
1.969945 |
1069 |
1 |
LungMetastasis |
no |
2.219945 |
GSM120672 | Erasmus |
ClaudinLow |
IBD |
PID |
ICR1 |
400002620 |
ER negative human primary breast tumor EA02014_41266_H133A_JA-1412 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
10.64480833 |
1412 |
1 |
LungMetastasisFree |
no |
10.64480833 |
GSM120673 | Erasmus |
Her2 |
IBD |
PID |
ICR2 |
400002621 |
ER negative human primary breast tumor EA02014_41267_H133A_JA-1455 |
DistantMetastasisFree |
5.36 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.357923333 |
1455 |
0 |
LungMetastasisFree |
no |
5.357923333 |
GSM120674 | Erasmus |
Her2 |
IBE |
PID |
ICR2 |
400002622 |
ER negative human primary breast tumor EA02014_41268_H133A_JA-1482 |
DistantMetastasisFree |
7.19 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.193989167 |
1482 |
1 |
LungMetastasisFree |
no |
7.193989167 |
GSM120675 | Erasmus |
Basal |
IBE |
WID |
ICR3 |
400002623 |
ER negative human primary breast tumor EA02014_41269_H133A_JA-1497 |
DistantMetastasisFree |
9.95 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
9.95355 |
1497 |
1 |
LungMetastasisFree |
no |
9.95355 |
GSM120676 | Erasmus |
Her2 |
IBE |
FID |
ICR4 |
400002624 |
ER negative human primary breast tumor EA02014_41270_H133A_JA-1501 |
DistantMetastasisFree |
6.14 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.142076667 |
1501 |
0 |
LungMetastasisFree |
no |
6.142076667 |
GSM120677 | Erasmus |
Basal |
IBE |
PID |
ICR4 |
400002625 |
ER negative human primary breast tumor EA02014_41271_H133A_JA-1524 |
DistantMetastasisFree |
5.7 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.696721667 |
1524 |
0 |
LungMetastasisFree |
no |
5.696721667 |
GSM120678 | Erasmus |
Normal |
IBE |
NA |
ICR4 |
400002626 |
ER negative human primary breast tumor EA02014_41272_H133A_JA-1416 |
DistantMetastasisFree |
8.87 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.86885 |
1416 |
0 |
LungMetastasisFree |
no |
8.86885 |
GSM120679 | Erasmus |
Basal |
IBE |
PID |
ICR2 |
400002627 |
ER negative human primary breast tumor EA02014_41273_H133A_JA-1535 |
DistantMetastasis |
3.47 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
3.469945 |
1535 |
1 |
LungMetastasisFree |
no |
3.469945 |
GSM120680 | Erasmus |
Basal |
IBE |
PID |
ICR3 |
400002628 |
ER negative human primary breast tumor EA02014_41274_H133A_JA-1563 |
DistantMetastasisFree |
8.61 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.606558333 |
1563 |
1 |
LungMetastasisFree |
no |
8.606558333 |
GSM120681 | Erasmus |
Her2 |
IBD |
PID |
ICR2 |
400002629 |
ER negative human primary breast tumor EA02014_41275_H133A_JA-1568 |
DistantMetastasisFree |
9.59 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
9.587433333 |
1568 |
0 |
LungMetastasisFree |
no |
9.587433333 |
GSM120682 | Erasmus |
Basal |
IBE |
WID |
ICR4 |
400002630 |
ER negative human primary breast tumor EA02014_41276_H133A_JA-1571 |
DistantMetastasisFree |
6.36 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.360655833 |
1571 |
1 |
LungMetastasisFree |
no |
6.360655833 |
GSM120683 | Erasmus |
Basal |
IBE |
FID |
ICR4 |
400002631 |
ER negative human primary breast tumor EA02014_41277_H133A_JA-1593 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
10.57104167 |
1593 |
1 |
LungMetastasisFree |
no |
10.57104167 |
GSM120684 | Erasmus |
Basal |
IBE |
PID |
ICR1 |
400002632 |
ER negative human primary breast tumor EA02014_41278_H133A_JA-1622 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
10.92895833 |
1622 |
0 |
LungMetastasisFree |
no |
10.92895833 |
GSM120685 | Erasmus |
Basal |
IBE |
WID |
ICR2 |
400002633 |
ER negative human primary breast tumor EA02014_41279_H133A_JA-1650 |
DistantMetastasisFree |
7.33 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.327869167 |
1650 |
0 |
LungMetastasisFree |
no |
7.327869167 |
GSM120686 | Erasmus |
Basal |
IBE |
PID |
ICR1 |
400002634 |
ER negative human primary breast tumor EA02014_41280_H133A_JA-1661 |
DistantMetastasisFree |
6.74 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.737705 |
1661 |
0 |
LungMetastasisFree |
no |
6.737705 |
GSM120687 | Erasmus |
Basal |
IBE |
PID |
ICR3 |
400002635 |
ER negative human primary breast tumor EA02014_41282_H133A_JA-1555 |
DistantMetastasis |
0.77 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
0.765027333 |
1555 |
1 |
LungMetastasisFree |
no |
0.765027333 |
GSM120688 | Erasmus |
Basal |
IBE |
WID |
ICR3 |
400002636 |
ER negative human primary breast tumor EA02014_41283_H133A_JA-1589 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
10.84153333 |
1589 |
1 |
LungMetastasisFree |
no |
10.84153333 |
GSM120689 | Erasmus |
Normal |
IBE |
NA |
ICR3 |
400002637 |
ER negative human primary breast tumor EA02014_41284_H133A_JA-854 |
DistantMetastasisFree |
5 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5 |
854 |
1 |
LungMetastasisFree |
no |
5 |
GSM120690 | Erasmus |
Basal |
IBE |
FID |
ICR4 |
400002638 |
ER negative human primary breast tumor EA02014_41285_H133A_JA-1821 |
DistantMetastasisFree |
7.32 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.3196725 |
1821 |
0 |
LungMetastasisFree |
no |
7.3196725 |
GSM120691 | Erasmus |
ClaudinLow |
IBD |
WID |
ICR1 |
400002639 |
ER negative human primary breast tumor EA02014_41286_H133A_JA-1828 |
DistantMetastasisFree |
8.57 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.565575 |
1828 |
0 |
LungMetastasisFree |
no |
8.565575 |
GSM120692 | Erasmus |
Basal |
IBE |
WID |
ICR2 |
400002640 |
ER negative human primary breast tumor EA02014_41287_H133A_JA-1858 |
DistantMetastasisFree |
7.39 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.385245833 |
1858 |
1 |
LungMetastasisFree |
no |
7.385245833 |
GSM120693 | Erasmus |
Her2 |
IBD |
FID |
ICR3 |
400002641 |
ER negative human primary breast tumor EA02014_41288_H133A_JA-1853 |
DistantMetastasisFree |
5.22 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.218579167 |
1853 |
0 |
LungMetastasisFree |
no |
5.218579167 |
GSM120694 | Erasmus |
Her2 |
IBE |
FID |
ICR3 |
400002642 |
ER negative human primary breast tumor EA02014_41289_H133A_JA-1871 |
DistantMetastasisFree |
7.18 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.177595833 |
1871 |
0 |
LungMetastasisFree |
no |
7.177595833 |
GSM120695 | Erasmus |
Basal |
IBE |
WID |
ICR4 |
400002643 |
ER negative human primary breast tumor EA02014_41290_H133A_JA-1938 |
DistantMetastasisFree |
7.49 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.489070833 |
1938 |
1 |
LungMetastasisFree |
no |
7.489070833 |
GSM120696 | Erasmus |
Basal |
IBE |
PID |
ICR2 |
400002644 |
ER negative human primary breast tumor EA02014_41291_H133A_JA-1939 |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
12.62568333 |
1939 |
1 |
LungMetastasisFree |
no |
12.62568333 |
GSM120697 | Erasmus |
Normal |
IBE |
NA |
ICR3 |
400002645 |
ER negative human primary breast tumor EA02014_41292_H133A_JA-1949 |
DistantMetastasisFree |
9.29 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
9.286883333 |
1949 |
0 |
LungMetastasisFree |
no |
9.286883333 |
GSM120698 | Erasmus |
Basal |
IBE |
WID |
ICR3 |
400002646 |
ER negative human primary breast tumor EA02014_41293_H133A_JA-1966 |
DistantMetastasisFree |
5.12 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.122950833 |
1966 |
1 |
LungMetastasisFree |
no |
5.122950833 |
GSM120699 | Erasmus |
Basal |
IBE |
PID |
ICR3 |
400002647 |
ER negative human primary breast tumor EA02014_41294_H133A_JA-1967 |
DistantMetastasisFree |
6.64 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.644808333 |
1967 |
0 |
LungMetastasisFree |
no |
6.644808333 |
GSM120700 | Erasmus |
Her2 |
IBE |
FID |
ICR4 |
400002648 |
ER negative human primary breast tumor EA02014_41295_H133A_JA-1976 |
DistantMetastasisFree |
6.06 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.060109167 |
1976 |
1 |
LungMetastasisFree |
no |
6.060109167 |
GSM120701 | Erasmus |
Basal |
IBE |
FID |
ICR3 |
400002649 |
ER negative human primary breast tumor EA02014_41296_H133A_JA-1978 |
DistantMetastasisFree |
5.75 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
5.748634167 |
1978 |
0 |
LungMetastasisFree |
no |
5.748634167 |
GSM120702 | Erasmus |
ClaudinLow |
IBD |
PID |
ICR2 |
400002650 |
ER negative human primary breast tumor EA02014_41297_H133A_JA-2001 |
DistantMetastasis |
0.36 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
0.363388 |
2001 |
1 |
LungMetastasis |
yes |
0.363388 |
GSM120703 | Erasmus |
Basal |
IBE |
FID |
ICR3 |
400002651 |
ER negative human primary breast tumor EA02014_41298_H133A_JA-2007 |
DistantMetastasisFree |
7.6 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.6010925 |
2007 |
1 |
LungMetastasisFree |
no |
7.6010925 |
GSM120704 | Erasmus |
LumA |
IBD |
WID |
ICR1 |
400002652 |
ER negative human primary breast tumor EA02014_41299_H133A_JA-2021 |
DistantMetastasisFree |
7.6 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
7.595628333 |
2021 |
0 |
LungMetastasisFree |
no |
7.595628333 |
GSM120705 | Erasmus |
Basal |
IBE |
PID |
ICR2 |
400002653 |
ER negative human primary breast tumor EA02014_41300_H133A_JA-2025 |
DistantMetastasisFree |
6.91 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
6.909835833 |
2025 |
1 |
LungMetastasisFree |
no |
6.909835833 |
GSM120706 | Erasmus |
ClaudinLow |
IBD |
FID |
ICR3 |
400002654 |
ER negative human primary breast tumor EA02014_41301_H133A_JA-2038 |
DistantMetastasisFree |
8.51 |
DiseaseFree |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
8.513658333 |
2038 |
1 |
LungMetastasisFree |
no |
8.513658333 |
GSM120707 | Erasmus |
Her2 |
IBD |
PID |
ICR2 |
400002655 |
ER negative human primary breast tumor EA02014_41302_H133A_JA-2024 |
DistantMetastasis |
1.8 |
Recurred/Progressed |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
1.800546667 |
2024 |
0 |
LungMetastasis |
yes |
1.800546667 |
Name | ||
---|---|---|
All Samples | Default | View |
Immune Benefit Status | View | |
Immunological Constant of Rejection | View | |
Molecular Subtype | View | |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
Immune Benefit Status | |
Immunological Constant of Rejection | |
Molecular Subtype |